Literature DB >> 18095157

Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice.

Rui-Sheng Duan1, Xin Yang, Zhi-Guo Chen, Ming-Ou Lu, Chris Morris, Bengt Winblad, Jie Zhu.   

Abstract

Chemokines and their receptors have been strongly implicated in the inflammatory process and pathogenesis of the neurodegenerative disorders, such as Alzheimer's disease (AD). In the present study, we examined the expression of chemokines, fractalkine, interferon-inducible protein-10 (IP-10) and macrophage inflammatory protein-1alpha (MIP-1alpha) by immunohistochemistry in the brain of transgenic mice APP SWE (Tg2576) at ages of 9, 11, and 17 months, which over-express a mutated form of human amyloid precursor protein (APP). Decreased fractalkine and increased IP-10 expression in cerebral cortex and hippocampus were found at ages of 9 and 17 months in Tg2576 mice when compared with age-matched control mice. On the contrary, MIP-1alpha expression showed no difference between Tg2576 mice and aged controls and was not influenced by ages. beta-amyloid (Abeta) positive plaques were co-located with the intense IP-10 expression. The finding suggests fractalkine and IP-10 may participate in the pathogenesis of AD; and could be new therapeutic strategies for neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18095157     DOI: 10.1007/s11064-007-9554-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  18 in total

1.  Fractalkine: moving from chemotaxis to neuroprotection.

Authors:  Diane Bérangère Ré; Serge Przedborski
Journal:  Nat Neurosci       Date:  2006-07       Impact factor: 24.884

2.  CXCR3 expression in human central nervous system diseases.

Authors:  S H Goldberg; P van der Meer; J Hesselgesser; S Jaffer; D L Kolson; A V Albright; F González-Scarano; E Lavi
Journal:  Neuropathol Appl Neurobiol       Date:  2001-04       Impact factor: 8.090

Review 3.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

Review 4.  Chemokines and their receptors in the central nervous system.

Authors:  A Bajetto; R Bonavia; S Barbero; T Florio; G Schettini
Journal:  Front Neuroendocrinol       Date:  2001-07       Impact factor: 8.606

5.  A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced.

Authors:  M Johnstone; A J Gearing; K M Miller
Journal:  J Neuroimmunol       Date:  1999-01-01       Impact factor: 3.478

Review 6.  Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.

Authors:  Laetitia Cartier; Oliver Hartley; Michel Dubois-Dauphin; Karl-Heinz Krause
Journal:  Brain Res Brain Res Rev       Date:  2005-02

7.  Microglial response to amyloid plaques in APPsw transgenic mice.

Authors:  S A Frautschy; F Yang; M Irrizarry; B Hyman; T C Saido; K Hsiao; G M Cole
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

8.  Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat.

Authors:  X Wang; J A Ellison; A L Siren; P G Lysko; T L Yue; F C Barone; A Shatzman; G Z Feuerstein
Journal:  J Neurochem       Date:  1998-09       Impact factor: 5.372

9.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

10.  Production and neuroprotective functions of fractalkine in the central nervous system.

Authors:  Tetsuya Mizuno; Jun Kawanokuchi; Kenji Numata; Akio Suzumura
Journal:  Brain Res       Date:  2003-07-25       Impact factor: 3.252

View more
  28 in total

1.  Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.

Authors:  Carmelina Gemma; Adam D Bachstetter; Paula C Bickford
Journal:  Aging Dis       Date:  2010-12-01       Impact factor: 6.745

Review 2.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

Authors:  Tony Wyss-Coray; Joseph Rogers
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 3.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

Review 4.  Microglia and inflammation in Alzheimer's disease.

Authors:  Shweta Mandrekar-Colucci; Gary E Landreth
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-04       Impact factor: 4.388

5.  2',3'-cAMP, 3'-AMP, 2'-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors.

Authors:  Elizabeth A Newell; Jennifer L Exo; Jonathan D Verrier; Travis C Jackson; Delbert G Gillespie; Keri Janesko-Feldman; Patrick M Kochanek; Edwin K Jackson
Journal:  Brain Res       Date:  2014-11-03       Impact factor: 3.252

6.  CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.

Authors:  Marius Krauthausen; Markus P Kummer; Julian Zimmermann; Elisabet Reyes-Irisarri; Dick Terwel; Bruno Bulic; Michael T Heneka; Marcus Müller
Journal:  J Clin Invest       Date:  2014-12-15       Impact factor: 14.808

7.  Microglial chemotactic signaling factors in Alzheimer's disease.

Authors:  James G McLarnon
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

8.  Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats.

Authors:  Adam D Bachstetter; Josh M Morganti; Jennifer Jernberg; Andrea Schlunk; Staten H Mitchell; Kaelin W Brewster; Charles E Hudson; Michael J Cole; Jeffrey K Harrison; Paula C Bickford; Carmelina Gemma
Journal:  Neurobiol Aging       Date:  2009-12-16       Impact factor: 4.673

9.  MFG-E8 regulates microglial phagocytosis of apoptotic neurons.

Authors:  Abby D Fuller; Linda J Van Eldik
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-01       Impact factor: 4.147

10.  Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer's disease.

Authors:  Bruce A Citron; Jessica N Saykally; Chuanhai Cao; John S Dennis; Melissa Runfeldt; Gary W Arendash
Journal:  Am J Neurodegener Dis       Date:  2015-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.